目的观察急性白血病病人联合化疗后粒细胞缺乏发热时抗生素经验性治疗的疗效。
Objective to observe the curative effect of experiential treatments to the infection after chemotherapy in acute leukemias.
急性粒细胞性白血病（AML）治疗的目标是治愈疾病。
目的观察四硫化四砷（TATS）治疗初治和复发急性早幼粒细胞白血病（APL）过程中细胞形态学及细胞遗传学变化，探讨其作用机制。
Objective To study the morphologic and cytogenetic change in acute promyelocytic leukemia (APL) patients during the tetra arsenic tetra sulfide (TATS) treatment and the mechanism of TATS.
目的了解雄黄治疗急性早幼粒细胞白血病（APL）的机制。
Objective To further understand the possible mechanism of realgar in the treatment of acute promyelocytic leukemia (APL).
结论：维甲酸、化疗、低分子肝素合用治疗急性早幼粒细胞性白血病并dic疗效明显，值得临床推广使用。
Conclusion: All-trans tretinoin acid chemotherapy in combination with low dosage heparin in the treatment of APL with DIC can obtain obvious effect.
目的：研究复方青黛片的主要成分雄黄治疗急性早幼粒细胞白血病（APL）的机制。
Objective: To study the possible mechanism of red orpiment, which is main component of composite indigo naturalis tablets, in the treatment of acute promyelocytic leukemia(APL).
目的：阐明氧化砷治疗急性早幼粒细胞白血病（APL）的机制。
Objective:To illustrate mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL).
A TRA诱导缓解治疗急性早幼粒细胞白血病202例。
APL patients were treated with ATRA for induction remission.
A TRA诱导缓解治疗急性早幼粒细胞白血病202例。
APL patients were treated with ATRA for induction remission.
应用推荐